Ishares Biotechnology Etf Market Value
| IBB Etf | USD 172.50 1.86 1.09% |
| Symbol | IShares |
iShares Biotechnology ETF's market price often diverges from its book value, the accounting figure shown on IShares's balance sheet. Smart investors calculate IShares Biotechnology's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IShares Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IShares Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IShares Biotechnology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IShares Biotechnology.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in IShares Biotechnology on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding iShares Biotechnology ETF or generate 0.0% return on investment in IShares Biotechnology over 90 days. IShares Biotechnology is related to or competes with IShares SP, IShares SP, IShares MSCI, IShares SP, IShares International, IShares Global, and IShares Global. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investm... More
IShares Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IShares Biotechnology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iShares Biotechnology ETF upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.09 | |||
| Information Ratio | 0.0456 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.68) | |||
| Potential Upside | 2.6 |
IShares Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IShares Biotechnology's standard deviation. In reality, there are many statistical measures that can use IShares Biotechnology historical prices to predict the future IShares Biotechnology's volatility.| Risk Adjusted Performance | 0.0847 | |||
| Jensen Alpha | 0.074 | |||
| Total Risk Alpha | 0.0233 | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.1607 |
IShares Biotechnology February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0847 | |||
| Market Risk Adjusted Performance | 0.1707 | |||
| Mean Deviation | 0.9968 | |||
| Semi Deviation | 0.9595 | |||
| Downside Deviation | 1.09 | |||
| Coefficient Of Variation | 995.65 | |||
| Standard Deviation | 1.27 | |||
| Variance | 1.62 | |||
| Information Ratio | 0.0456 | |||
| Jensen Alpha | 0.074 | |||
| Total Risk Alpha | 0.0233 | |||
| Sortino Ratio | 0.0534 | |||
| Treynor Ratio | 0.1607 | |||
| Maximum Drawdown | 5.75 | |||
| Value At Risk | (1.68) | |||
| Potential Upside | 2.6 | |||
| Downside Variance | 1.18 | |||
| Semi Variance | 0.9206 | |||
| Expected Short fall | (1.15) | |||
| Skewness | 0.4164 | |||
| Kurtosis | (0.01) |
iShares Biotechnology ETF Backtested Returns
At this point, IShares Biotechnology is very steady. iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of 0.0632, which attests that the entity had a 0.0632 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for iShares Biotechnology ETF, which you can use to evaluate the volatility of the entity. Please check out IShares Biotechnology's Downside Deviation of 1.09, risk adjusted performance of 0.0847, and Market Risk Adjusted Performance of 0.1707 to validate if the risk estimate we provide is consistent with the expected return of 0.0799%. The etf retains a Market Volatility (i.e., Beta) of 0.73, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, IShares Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding IShares Biotechnology is expected to be smaller as well.
Auto-correlation | 0.13 |
Insignificant predictability
iShares Biotechnology ETF has insignificant predictability. Overlapping area represents the amount of predictability between IShares Biotechnology time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iShares Biotechnology ETF price movement. The serial correlation of 0.13 indicates that less than 13.0% of current IShares Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 6.13 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Biotechnology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Biotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Biotechnology Etf:Check out IShares Biotechnology Correlation, IShares Biotechnology Volatility and IShares Biotechnology Performance module to complement your research on IShares Biotechnology. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.